EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease.
Vaught DB, Merkel AR, Lynch CC, Edwards J, Tantawy MN, Hilliard T, Wang S, Peterson T, Johnson RW, Sterling JA, Brantley-Sieders D.
Vaught DB, et al. Among authors: sterling ja.
JBMR Plus. 2021 Mar 9;5(4):e10465. doi: 10.1002/jbm4.10465. eCollection 2021 Apr.
JBMR Plus. 2021.
PMID: 33869989
Free PMC article.